We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Bladder Cancer

Journal Scan / Research · February 17, 2021

Bladder Tumor Subtype Commitment Occurs in Carcinoma In-Situ Driven by Key Signaling Pathways

Cancer Research

 

Additional Info

Cancer Research
Bladder Tumor Subtype Commitment Occurs in Carcinoma In-Situ Driven by Key Signaling Pathways Including ECM Remodeling
Cancer Res 2021 Jan 20;[EPub Ahead of Print], A Wullweber, R Strick, F Lange, D Sikic, H Taubert, S Wach, B Wullich, S Bertz, V Weyerer, R Stoehr, J Breyer, M Burger, A Hartmann, PL Strissel, M Eckstein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading